Entries by Andrea Durkin

What Today’s USMCA Debate Has to Do with The Drugs of Tomorrow

The political winds seem to be blowing in favor of a Congressional vote on the U.S.-Mexico-Canada Free Trade Agreement (USMCA) yet this fall. But before they vote, some Members of Congress want to talk over a few issues with the Trump administration’s negotiators. One is intellectual property protections for the U.S. biopharmaceutical industry. As important as it is, the issue of data protection for biologic drugs is not well understood.

Coming and Going, the U.S. Wins from Foreign Direct Investment

Foreign direct investment (FDI) is a vehicle for gaining entry into growth markets. In theory and in general, it’s a win-win. In practice and locally, it will depend on each deal. Global FDI flows have taken a dive, in part due to a souring investment climate and uncertainties in trade policies, but they are critical for growth in developing and developed markets alike.